20248 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids Retinoic acids Salts thereof
SUBSTITUTED PYRIDINES FOR USE IN TREATING OR PREVENTING INFLAMMATORY DISEASES OR DISEASES ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE
#2COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER
#32,4 DNP and Prodrugs Thereof for Treatment of Cancer
#4EXOSOMES ISOLATED FROM MESENCHYMAL STEM CELLS AND USES THEREOF
#5PHARMACEUTICAL COMPOSITIONS OF TRETINOIN AND METHODS OF PRODUCING SUCH COMPOSITIONS
#6HAIR REGROWTH TOPICAL COMPOSITION
#7STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#8PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING RENAL CYSTIC CILIOPATHY
#9COMPOSITIONS AND METHODS RELATED TO INHIBITION OF ADENOMAS AND ADENOCARCINOMAS
#10DRUG DELIVERY SYSTEM, TREATMENT KIT, AND METHOD FOR INHIBITING PROLIFERATION OR METASTASIS OF CANCER CELL
#11RETINOIC ACID-ALCOHOL AMINE COMPLEX, PREPARATION METHOD AND APPLICATION THEREOF
#12COMPOSITIONS AND METHODS FOR SKIN CARE
#13METHODS AND COMPOSITIONS FOR CAS IMMUNE TOLERANCE INDUCTION TO SUPPORT CRISPR-CAS IN VIVO GENE EDITING
#14SUBSTANCE FOR PROMOTING REGENERATION AND REPAIR OF ORGANS OF MAMMALS AND USE THEREOF
#15METHOD FOR INDUCING IN-SITU REGENERATION OF MAMMAL AND USE THEREOF
#16COMPOSITIONS COMPRISING ENCAPSULATED TRETINOIN
#17INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1), COMBINATIONS AND USES THEREOF
#18RETINOL ACID PATHWAY MODULATORS FOR TREATMENT OF CONGENITAL VASCULAR MALFORMATION
#19COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#20SYNERGISTIC COMPOSITIONS FOR ENHANCED HAIR GROWTH AND METHODS FOR TREATING HAIR LOSS
#21COMPOSITIONS AND METHODS FOR LOCAL DELIVERY OF PHARMACEUTICAL AGENTS TO TREAT CANCER
#22IMMUNOREGULATORY MICROPARTICLES FOR MODULATING INFLAMMATORY ARTHRITIDES
#23PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING RENAL CYSTIC CILIOPATHY
#24COMPOSITIONS AND METHODS FOR TREATMENT OF PSORIASIS
#25USE OF RETINOIDS FOR TREATMENT OF ATRIAL FIBRILLATION
#26FORMULATIONS AND METHODS FOR SKIN CARE
#27COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS
#28INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1), COMBINATIONS AND USES THEREOF
#29METHODS FOR TREATING NEUROBLASTOMA
#30PHARMACY COMPOUNDED PRESCRIPTION COMPOSITIONS FOR HAIR GROWTH
#31ANTIBODY TARGETING B CELL MATURATION ANTIGEN AND RELATED PRODUCTS THEREOF AND MEDICAL APPLICATIONS
#32COMBINATION TREATMENT OF TUMORS
#33THERAPEUTIC AGENT FOR CANCER
#34METHOD OF VIRAL INHIBITION
#35RXR AGONISTS IN EYE DISORDERS
#36METHOD AND MEDICAMENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#37WATER-SOLUBLE CANNABINOID/RETINOID BLEND FORMULATIONS AND METHODS OF THEIR MAKING
#38P53 PEPTIDOMIMETIC MACROCYCLES
#39PHYSIOLOGICALLY ACTIVE SUBSTANCE CARRIER
#40COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#41RETINOIC ACID COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
#42PHARMACEUTICAL COMPOSITION INCLUDING RETINOIC ACID AND CARBOHYDRATE AND USE THEREOF
#43Formulations and methods for skin care
#44Formulations and methods for skin care or hyaluronic acid synthesis
#45FORMULATION FOR INCREASING HAIR GROWTH AND REDUCING HAIR THINNING
#46TISSUE REPAIR
#47METHODS OF TREATING ACUTE CORONARY SYNDROME USING 3,3'-DIINDOLYLMETHANE
#48COMPOSITION COMPRISING A DIINDOLYLMETHANE AND A RETINOID TO TREAT A SKIN CONDITION
#49FORMULATIONS FOR EXTENDING LIFESPAN AND HEALTHSPAN
#50Dermal Application of Retinoic Acid Receptor Agonists for Amelioration of Hypertrophic Scar
#51NEW METHOD TO IMPROVE NK CELLS CYTOTOXICITY
#52Patient Treatment Via Teratogenic Pharmaceutical Compounds
#53INTRACELLULAR TARGETED NANOCARRIERS: TOWARDS CONTROLLED DRUG DELIVERY FOR NONINVASIVE NEUROREGENERATION TREATMENT
#54Oral Pharmaceutical Composition, Method for Fabricating Thereof, and Kit for Treating Cancer
#55NEW METHOD TO IMPROVE THE ANTI-TUMORAL ACTIVITY OF MACROPHAGES
#56COMPOSITION USED FOR THERAPEUTIC TREATMENT OF SKIN DISEASE
#57METHODS FOR TREATING NEUROBLASTOMA
#58COMPOUNDS AND METHODS FOR TREATING CONGENITAL ERYTHROPOIETIC PORPHYRIA
#59SKIN SOLUTION WITH SOLUBILIZED BAKUCHIOL
#60CD200 INHIBITORS AND METHODS OF USE THEREOF
#61USE OF REAGENT FOR DETECTING RETINOL METABOLITE IN PREPARATION OF TOOL FOR DIAGNOSING AND/OR TREATING PNEUMOCONIOSIS
#62Physiologically active substance carrier
#63OLIGONUCLEOTIDES FOR PMS2 MODULATION
#64Immunoregulatory microparticles for modulating inflammatory arthritides
#65Method of viral inhibition
#66ALL-TRANS RETINOIC ACID ENHANCES RADIOTHERAPY AND OVERCOMES IMMUNE SUPPRESSION FOR CANCER THERAPY
#67OMEGA-3 POLYUNSATURATED FATTY ACIDS FOR TREATING / PREVENTING MALE INFERTILITY IN PREPUBERTAL CANDIDATES FOR GONADOTOXIC THERAPIES
#68DELIVERY SYSTEMS
#69COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING ADENOID CYSTIC CARCINOMA
#70COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#71COMBINATION THERAPIES WITH EHMT2 INHIBITORS
#72USE OF TETRANDRINE IN COMBINATION WITH ALL-TRANS RETINOIC ACID IN PREPARATION OF MEDICAMENT FOR TREATING PNEUMOCONIOSIS
#73Spirolactone compounds
#74COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIPID-RELATED DISORDERS
#75COMBINATION THERAPY OF ATRA OR OTHER RETINOIDS WITH IMMUNOTHERAPEUTIC AGENTS BINDING TO BCMA
#76VITAMIN A FOR USE IN THE TREATMENT OF TRAUMATIC BRAIN INJURY
#77DELIVERY SYSTEMS
#78SEMIFLUORINATED ALKANE COMPOSITIONS
#79METHOD FOR SELECTING CANCER PATIENTS FOR WHOM COMBINATION THERAPY WITH RETINOID AND CANCER THERAPEUTIC AGENT IS EFFECTIVE, AND COMBINATION MEDICAMENT WITH RETINOID AND CANCER THERAPEUTIC AGENT
#80ORAL LIQUID PHARMACEUTICAL COMPOSITIONS OF ISOTRETINOIN
#81DELIVERY SYSTEMS
#82THERMOGEL SUSTAINED-RELEASE MICROPARTICLE-BASED DELIVERY TO A PARANASAL AND/OR NASAL CAVITY
#83EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION
#84COMPOSITION AND METHODS OF RETINOIC ACID
#85NUTRITIONAL FORMULA
#86COMPOSITIONS AND METHODS FOR TREATING CHRONIC MYELOMONOCYTIC LEUKEMIA
#87COMPOSITION AND METHOD FOR TREATING DERMATOLOGICAL DISORDERS USING RETINAMIDES
#88EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERS
#89Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane
#90INDUCTION OF SYNTHETIC LETHALITY WITH EPIGENETIC THERAPY
#91COMPOUNDS FOR USE IN THE TREATMENT OF LEUKEMIA
#92SUSTAINED-RELEASE 9-CIS RETINOIC ACID IMPLANTABLE DRUG DELIVERY PELLETS FOR THE PREVENTION OF POSTSURGICAL EDEMA AND LYMPHEDEMA
#93Compositions and methods for treating lysosomal disorders
#94TARGETING GLIOBLASTOMA STEM CELLS THROUGH THE TLX-TET3 AXIS
#95COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY
#96TREATMENT OF SKIN DISORDERS WITH TOPICAL COMPOSITIONS COMPRISING TAPINAROF AND A PDE4 INHIBITOR
#97POLYMERIC EMULSION DELIVERY SYSTEMS
#98NOVEL SALT OF TERPHENYL COMPOUND
#99DELIVERY SYSTEMS FOR RELEASE OF ACTIVE COMPOUNDS
#100TREATMENT OF MULTIPLE MYELOMA
#101METHODS OF TREATING LSD1-RELATED DISEASES AND DISORDERS WITH LSD1 INHIBITORS
#102ISOTRETINOIN FORMULATIONS AND USES AND METHODS THEREOF
#103CD200 inhibitors and methods of use thereof
#104USE OF RETINOIC ACID RECEPTOR (RAR) AGONISTS FOR REVERSING, PREVENTING, OR DELAYING CALCIFICATION OF AORTIC VALVE
#105TREATMENT OF SKIN DISORDERS WITH TOPICAL COMBINATION COMPOSITIONS COMPRISING TAPINAROF AND AN ADDITIONAL AHR ACTIVATOR
#106COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
#107TREATMENT OF IDIOPATHIC HYPOHIDROSIS
#108TOPICAL JAK INHIBITOR COMBINATION COMPOSITIONS FOR TREATMENT OF INFLAMMATORY SKIN CONDITIONS
#109METHOD FOR IDENTIFYING TREATMENT OF INFECTIONS CAUSED BY PATHOGENS OF DIVERSE ORIGIN
#110BENZOQUINONE DERIVATIVES FOR THE TREATMENT OF BLADDER CANCER
#111DIFFUSION ENHANCING COMPOUNDS AND THEIR USE ALONE OR WITH THROMBOLYTICS
#112COMPOSITIONS COMPRISING HDAC INHIBITORS AND RETINOIDS
#113Compositions and methods for skin rejuvenation
#114KITS FOR DERMAL CARE
#115TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS
#116Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
#117BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS
#118PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE
#119Sensitization of cancer cells to differentiation therapy with mitochondrial uncoupler niclosamide ethanolamine
#120DELIVERY SYSTEMS FOR RELEASE OF ACTIVE COMPOUNDS
#121CAPSULE WITH INTERNAL DIAPHRAGM FOR IMPROVED BIOAVAILABILITY
#122COMBINATION OF NASAL GENE DELIVERY AND ORAL CINNAMIC ACID, OLEAMIDE OR GEMFIBROZIL FOR LYSOSOMAL STOARGE DISORDERS
#123COMBINATION THERAPEUTICS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE AND OTHER DISEASES
#124METHOD FOR INHIBITING CORONAVIRUS AND METHOD FOR TREATING DISEASE ASSOCIATED WITH CORONAVIRUS INFECTION
#125Compositions and methods for treating patients suffering from glioma or leukemia
#126Bone Morphogenetic Protein Pathway Activation, Compositions for Ossification, and Methods Related Thereto
#127Method of treating adenoid cystic carcinoma
#128Method of viral inhibition
#129TISSUE REPAIR
#130COMPOSITION AND METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
#131Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane
#132Composition and methods for stimulating clearance of amyloid-beta protein
#133Methods of Treatment, Genetic Screening, and Disease Models for Heart Conditions Associated with RBM20 Deficiency
#134REGULATING MUSCLE PHYSIOLOGY AND ENERGY METABOLISM USING CRYM
#135Esters for treatment of ocular inflammatory conditions
#136METHODS FOR TREATING NEUROBLASTOMA
#137Physiologically active substance carrier
#138Stabilized microcapsules, method of their preparation and uses thereof
#139Stabilized microcapsules, method of their preparation and uses thereof
#140STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#141MODULATORS OF PROSTATE-SPECIFIC G-PROTEIN RECEPTOR (PSGR/OR51E2) AND METHODS OF USING SAME
#142ALL-TRANS RETINOIC ACID LIPOSOME FORMULATION, AND PREPARATION AND USE THEREOF
#143Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#144IMMUNOTHERAPY FOR CANCER
#145COMBINATION COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THEREOF
#146ISOTRETINOIN ORAL-MUCOSAL FORMULATIONS AND METHODS FOR USING SAME
#147EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION
#148PYRROLE DERIVATIVES AS ACC INHIBITORS
#149KRAS peptide vaccine compositions and method of use
#150Methods for treatment of psoriasis with an anti-Apo B100 antibody
#151Compositions and methods for treating the eye
#152ANTI-GD2 ANTIBODY FOR THE TREATMENT OF NEUROBLASTOMA
#153COMPOSITIONS AND METHODS FOR LOCAL DELIVERY OF PHARMACEUTICAL AGENTS TO TREAT CANCER
#154Bispecific antibodies specific for treating hematological malignancies
#155TREATMENT OF A SUBTYPE OF ASD
#156Prevention and treatment of inflammatory conditions
#157Microparticle systems and their use for the treatment of multiple sclerosis
#158METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATIC AND METABOLIC DISEASES
#159MODULATING NUCLEAR RECEPTORS AND METHODS OF USING SAME
#160FIBRILLAR-PROTEIN BASED COMPOSITIONS AND USES THEREOF
#161ROS-RESPONSIVE MICRONEEDLE PATCH FOR ACNE VULGARIS TREATMENT
#162Spirolactone compounds
#163Luminescent layered composition and a method for using the composition
#164Compositions and methods for the isolation and/or generation of specific CD4+ and CD8+ T-cell subsets
#165METHODS OF TREATING MINIMAL RESIDUAL CANCER
#166METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE
#167CD200 inhibitors and methods of use thereof
#168Induction of synthetic lethality with epigenetic therapy
#169COMPOSITIONS AND METHODS FOR THE TREATMENT OF LUNG EMPHYSEMA AND OTHER FORMS OF COPD
#170Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
#171Compositions and methods for treating the eye
#172Pharmaceutical compositions comprising silica microspheres
#173Patient treatment via teratogenic pharmaceutical compounds
#174CONTROLLED RELEASE FORMULATIONS FOR THE INDUCTION AND PROLIFERATION OF BLOOD CELLS
#175Lipin-1 as a novel therapy target of muscular dystrophy
#176Delivery systems
#177Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by
#178Composition and methods of treating acne and photoaging
#179TOPICAL FOAM COMPOSITION
#180COMPOSITION USED FOR THERAPEUTIC TREATMENT OF SKIN DISEASE
#181Combination of topical medications for the treatment of skin diseases and methods of use
#182Sustained-release 9-cis retinoic acid implantable drug delivery pellets for the prevention of postsurgical edema and lymphedema
#183COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA
#184METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE
#185TARGETING GLIOBLASTOMA STEM CELLS THROUGH THE TLX-TET3 AXIS
#186TOPICAL COMPOSITIONS AND METHODS FOR TREATING ACNE VULGARIS
#187Composition and methods for stimulating clearance of amyloid-beta protein
#188Isotretinoin formulations and uses and methods thereof
#189Anti-GD2 antibody
#190Use of ALDH1A and agonist, catalyst and inhibitor thereof
#191Hybrid herbal and drug composition and method of formulation
#192Treatment of cancer with combinations of agents
#193Scalable Vitamin Composition Unit Dosage for the Treatment of Fat-Soluble Vitamin Deficiencies
#194Modulators of prostate-specific g-protein receptor (PSGR/OR51E2) and methods of using same
#195Semifluorinated alkane compositions
#196Esters for Treatment of Ocular Inflammatory Conditions
#197Phosphoserine containing compositions for immune tolerance induction
#198Esters for treatment of ocular inflammatory conditions
#199COMPOSITIONS AND METHODS OF TREATMENT FOR MVID AND RELATED DISEASES
#200COMBINATION THERAPY FOR HEAD AND NECK CANCER
#201Liposomes for drug delivery and methods for preparation thereof
#202Freeze dried active composition and a system for using the same
#203COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL
#204Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#205ENHANCEMENT OF THE EFFICACY OF THERAPEUTIC PROTEINS
#206Isotretinoin oral-mucosal formulations and methods for using same
#207Isotretinoin oral-mucosal formulations and methods for using same
#208PHARMACEUTICAL COMPOSITIONS FOR TREATING ACNE
#209Methods of treating diseases associated with high-fat diet and vitamin a deficiency using retinoic acid receptor agonists
#210DERIVATIZED POLYGLUCOSAMINES FOR DELIVERY OF SMALL MOLECULES, PEPTIDES, AND PROTEINS
#211CANCER STEM CELL PROLIFERATION INHIBITOR
#212Combination therapies with EHMT2 inhibitors
#213Compositions and methods for treating patients suffering from glioma or leukemia
#214ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME
#215CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
#216COMPOSITION AND METHOD FOR THE TOPICAL TREATMENT OF SEVERE ACNE
#217Physiologically active substance carrier
#218Coated edible plant-derived microvesicle compositions and methods for using the same
#219Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer
#220Compositions and Methods for Treating Neurologic Disorders
#221Composition and method for treating neuronal ceroid lipofuscinosis
#222Methods and compositions for the treatment of acne
#223Esters for treatment of ocular inflammatory conditions
#224TARGETED DRUG DELIVERY AND THERAPEUTIC METHODS USING APO-E MODIFIED LIPID NANOPARTICLES
#225Topical pharmaceutical compositions for treating skin conditions
#226Topical pharmaceutical compositions for treating skin conditions
#227NONSTEROIDAL IMMUNOMODULATING KIT AND COMPOSITION AND USES THEREOF
#228Polymeric emulsion delivery systems
#229COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS
#230All-trans retinoic acid injectant and application
#231Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of bladder cancer
#232EXCIPIENT SYSTEM FOR TOPICAL DELIVERY OF PHARMACEUTICAL AGENTS
#233Nutritional formula
#234Hybrid herbal and drug composition and method of formulation
#235Pharmaceutical compositions comprising silica microspheres
#236BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS
#237Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
#238Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by
#239Methods for treatment of adenoid cystic carcinoma
#240COMPOSITIONS INCLUDING ENCAPSULATED ISOTRETINOIN AND METHODS FOR USE THEREOF
#241Compositions and methods to affect skin irritation
#242Ophthalmic compositions
#243Ophthalmic compositions
#244COMPOUND FOR USE IN THE TREATMENT OF A BLOOD VESSEL DISEASE
#245Non-aqueous topical compositions comprising a halogenated salicylanilide
#246Challenge test for diagnosing subtypes of ASD
#247Method of identifying ASD phenotype 1 patients
#248Treatment of a subtype of ASD
#249Compositions and methods to affect skin irritation
#250Delivery systems
#251Retinaldehyde containing compositions and methods of use
#252Polycomplexes of poly-lysine compounds for preventing and/or combatting amyotrophic lateral sclerosis
#253Diffusion enhancing compounds and their use alone or with thrombolytics
#254Combinations of LSD1 inhibitors for the treatment of hematological malignancies
#255Oil-in-water emulsions including retinoic acid
#256DNA Methylation Landscapes of Post-Traumatic Stress Disorder (PTSD) Susceptibility and Resilience and Novel Therapeutics of PTSD Derived Thereof
#257Delivery systems
#258Targeting glioblastoma stem cells through the TLX-TET3 axis
#259Methods of treating diseases associated with high-fat diet and vitamin a deficiency using retinoic acid receptor agonists
#260Biomembrane, closed structure with biomembrane characteristics or cellular compartment derived from natural sources and/or self-assembly techniques, preparation method and applications thereof
#261Methods and compositions for the treatment of acne
#262METHOD OF ACNE TREATMENT BY CONCOMITANT TOPICAL ADMINISTRATION OF BENZOYL PEROXIDE AND TRETINOIN
#263METHOD OF ACNE TREATMENT BY CONCOMITANT TOPICAL ADMINISTRATION OF BENZOYL PEROXIDE AND TRETINOIN
#264COMPOSITIONS COMPRISING ENCAPSULATED TRETINOIN
#265COMPOSITIONS AND METHODS FOR SKIN CARE
#26613-cis-RAMBA retinamides that degrade MNKs for treating cancer
#267Composition comprising a diindolylmethane and a retinoid to treat a skin condition
#268METHODS OF TREATING ACNE USING NANOEMULSION COMPOSITIONS
#269Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
#270Method for using small molecule compounds to induce human tumor cells to be directly reprogrammed into non-oncogenic cells
#271COMPOSITIONS AND METHODS OF TREATMENT FOR MVID AND RELATED DISEASES
#272Semifluorinated alkane compositions
#273CD200 inhibitors and methods of use thereof
#274Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne
#275BENZOQUINONE DERIVATIVE E3330 IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF COLON CANCER
#276Compositions and methods of treating acne and photoaging
#277Isotretinoin formulations and uses and methods thereof
#278TREATMENT OF EPITHELIAL LAYER LESIONS
#279Capsule with internal diaphragm and solid ingredients
#280Patient treatment via teratogenic pharmaceutical compounds
#281Capsule with volume-adjustable internal diaphragm
#282Retinoid compositions and methods of increasing immune cell-mediated killing of IDH mutant cancer cells
#283Cream gels comprising at least one retinoid and benzoyl peroxide
#284Polyphenolic polymer to make water-insoluble molecules become water-soluble
#285Compound and pharmaceutical composition for tumor imaging and tumor therapy
#286Prevention and treatment of inflammatory conditions
#287ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#288Nano-fibular nanoparticle polymer-drug conjugate for sustained dermal delivery of retinoids
#289Compositions comprising water dispersible nanoparticles of a retinoid compound
#290Scalable vitamin composition unit dosage for the treatment of fat-soluble vitamin deficiencies
#291Low toxicity topical active agent delivery system
#292Arsenic trioxide for treatment of PIN1-associated disorders
#293Methods for treating acute myeloid leukemia and nanoparticle complexes of miR-22 utilized therein
#294Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer
#295Composition and method for treating skin conditions
#296Modulators of prostate-specific G-protein receptor (PSGR/OR51E2) and methods of using same
#297ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
#298Compositions and methods to affect skin irritation
#299Combination immunotherapy for treating cancer
#300ONCE DAILY ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN